Search | Clinical Trials Finder

ClinicalTrials.gov public records Last synced Jul 21, 2026, 7:00 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1–16 of 16 matching trials from the live ClinicalTrials.gov search.

Local D1 index available.

Filters: Condition: Premature Ejaculation Clear all

Conditions: Ejaculation
Interventions: UK-390,957; Drug
Lead sponsor: Pfizer; Industry
Eligibility: 18 Years and older · Male only
Enrollment: 1,058 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2006
U.S. locations: 46
States / cities: Tucson, Arizona • Anaheim, California • Atherton, California + 43 more

Conditions: Premature Ejaculation
Interventions: Placebo, Promescent Lidocaine Spray; Drug
Lead sponsor: Eugene Y Rhee, MD; Other
Eligibility: 18 Years and older · Male only
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2015
U.S. locations: 2
States / cities: Los Angeles, California • San Diego, California

Conditions: Ejaculation
Interventions: UK-390,957; Drug
Lead sponsor: Pfizer; Industry
Eligibility: 18 Years and older · Male only
Enrollment: 138 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005
U.S. locations: 14
States / cities: Birmingham, Alabama • San Bernardino, California • Metairie, Louisiana + 11 more

Conditions: Premature Ejaculation
Interventions: IX-01, Placebo; Drug
Lead sponsor: Ixchelsis Limited; Industry
Eligibility: 18 Years to 60 Years · Male only
Enrollment: 88 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2015
U.S. locations: 8
States / cities: San Diego, California • Aventura, Florida • West Palm Beach, Florida + 5 more

Conditions: Premature Ejaculation
Interventions: IX-01 400 mg, Placebo, IX-01 800 mg, IX-01 1200 mg; Drug
Lead sponsor: Ixchelsis Limited; Industry
Eligibility: 18 Years to 60 Years · Male only
Enrollment: 239 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017
U.S. locations: 29
States / cities: Mobile, Alabama • Chandler, Arizona • Mesa, Arizona + 25 more

Conditions: Premature Ejaculation
Interventions: pagoclone; Drug
Lead sponsor: Endo USA Inc., a Keenova Therapeutics Company; Industry
Eligibility: 18 Years to 55 Years · Male only
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006
U.S. locations: 16
States / cities: Homewood, Alabama • San Diego, California • Aurora, Colorado + 12 more

Conditions: Ejaculation
Interventions: Treatment sequence 2, Treatment sequence 1; Drug
Lead sponsor: Janssen Research & Development, LLC; Industry
Eligibility: 18 Years and older · Male only
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2012
U.S. locations: 6
States / cities: Anniston, Alabama • Tempe, Arizona • Costa Mesa, California + 3 more

Conditions: Obstetric Labour, Premature, Premature Ejaculation
Interventions: GSK221149; Drug
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 18 Years to 50 Years
Enrollment: 36 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: Started 2007
U.S. locations: 1
States / cities: Tacoma, Washington

Conditions: Obstetric Labour, Premature, Premature Ejaculation
Interventions: GSK557296; Drug
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 18 Years to 45 Years · Male only
Enrollment: 42 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: Started 2007
U.S. locations: 1
States / cities: Evansville, Indiana

Conditions: Premature Ejaculation
Interventions: Placebo, PSD502; Drug
Lead sponsor: Plethora Solutions Ltd; Industry
Eligibility: 18 Years and older · Male only
Enrollment: 121 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2021
U.S. locations: 21
States / cities: Birmingham, Alabama • Mobile, Alabama • Sherman Oaks, California + 18 more

Conditions: Premature Ejaculation
Interventions: OnabotulinumtoxinA, Normal Saline; Drug
Lead sponsor: Allergan; Industry
Eligibility: 18 Years to 50 Years · Male only
Enrollment: 59 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2017
U.S. locations: 6
States / cities: San Diego, California • Torrance, California • Middlebury, Connecticut + 3 more

Conditions: Ejaculation
Interventions: UK-390,957; Drug
Lead sponsor: Pfizer; Industry
Eligibility: 18 Years and older · Male only
Enrollment: 460 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2005
U.S. locations: 51
States / cities: Tucson, Arizona • Anaheim, California • Atherton, California + 48 more

Conditions: Ejaculatory Dysfunction, Premature Ejaculation, Delayed Ejaculation, Anorgasmia, Anejaculation, Dysejaculation, Dysorgasmia
Interventions: Not listed
Lead sponsor: Charitable Union for the Research and Education of Peyronie's Disease; Other
Eligibility: 18 Years and older
Enrollment: 500 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2029
U.S. locations: 1
States / cities: Orem, Utah

Conditions: Premature Ejaculation
Interventions: GSK557296, placebo; Drug
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 18 Years to 50 Years · Male only
Enrollment: 77 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2011
U.S. locations: 6
States / cities: San Diego, California • San Jose, California • Fort Wayne, Indiana + 3 more

Conditions: Erectile Dysfunction, Sexual Dysfunction
Interventions: Placebo, Dapoxetine, PDE5I (phosphodiesterase-5 inhibitor); Drug
Lead sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.; Industry
Eligibility: 18 Years and older · Male only
Enrollment: 495 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2011
U.S. locations: 19
States / cities: Decatur, Alabama • Huntsville, Alabama • Englewood, Colorado + 16 more

Conditions: Premature Ejaculation
Interventions: PSD502, contains a mixture of lidocaine and prilocaine, Placebo; Drug
Lead sponsor: Plethora Solutions Ltd; Industry
Eligibility: 18 Years and older · Male only
Enrollment: 256 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2009
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Search by objective public record fields.

Assessment Of Safety Of UK-390,957

Efficacy of Promescent Lidocaine Spray in Men With Premature Ejaculation

Assessment Of Efficacy and Safety UK-390,957 In Men With Premature Ejaculation

IX-01 Effect on Intravaginal Ejaculatory Latency Time (IELT) and Patient Reported Outcomes in Men With Premature Ejaculation (PE)

IX-01 Effect on Intravaginal Ejaculatory Latency Time (IELT), Patient Reported Outcomes and Safety in Men With Premature Ejaculation (PE)

Exploratory Study of Pagoclone in Men With Premature Ejaculation.

A Pharmacodynamic Study of Dapoxetine Concomitantly Administered in Participants Taking Terazosin

A Study To Assess The Pharmacokinetics Of Different Modified Release Formulations Of GSK221149 In Healthy Adult Subjects

A First Time in Human Study in Healthy Male Volunteers for Compound GSK557296.

PSD502 in Subjects With Premature Ejaculation

A Safety and Efficacy Study of OnabotulinumtoxinA in Premature Ejaculation

Assessment of Efficacy and Safety of UK-390,957 in Men With Premature Ejaculation

Ejaculatory and Orgasmic Dysfunction Registry

A Study To Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Two Oral Doses of GSK557296 in a Study in Men With Premature Ejaculation

Concomitant Use of PriLigy in Men Treated for Erectile Dysfunction

Efficacy, Safety and Tolerability of PSD502 (a Topical Anesthetic) in the Treatment Premature Ejaculation